April 24, 2012 The Honorable Tom Harkin Chairman U.S. Senate Committee on Health, Education, Labor, and Pensions 731 Hart Senate Office Building Washington, DC 20510

First Page		Document Content
Date: 2012-04-24 17:34:05 Health policy Healthcare reform in the United States Federal assistance in the United States Presidency of Lyndon B. Johnson False Claims Act Pharmaceutical fraud Pharmaceutical industry Food and Drug Administration Medicare Pharmaceuticals policy Pharmaceutical sciences Pharmacology		April 24, 2012 The Honorable Tom Harkin Chairman U.S. Senate Committee on Health, Education, Labor, and Pensions 731 Hart Senate Office Building Washington, DC 20510 Add to Reading List Source URL: www.citizen.org Download Document from Source Website File Size: 215,08 KB Share Document on Facebook

	Federal Register / Vol. 83, NoFriday, March 16, Proposed Rules Food and Drug Administration 21 CFR Part 1130 DocID: 1xVJS - View Document
	What is a Vulnerability Disclosure Policy and Why You Need One VDPs work and they protect assets. That’s why the U.S. Department of Justice, the European Commission, and the U.S. Food & Drug Administration recommend th DocID: 1xVfx - View Document
	Notice to Industry: Additional Tobacco Products Now Regulated by the Food and Drug Administration DocID: 1xVey - View Document
	DEPARTMENT OF HEALTH AND HUMAN S ERVICES _________________________________________________________________________________________________________ Food and Drug Administration Center for T obacco Products 9200 Corporate DocID: 1xUvW - View Document
	DEPARTMENT OF HEALTH AND HUMAN SERVICES _________________________________________________________________________________________________________ Food and Drug Administration Center for Tobacco ProductsNew Hampshi DocID: 1xTPU - View Document